Attenuation of Candida albicans virulence with focus on disruption of its vacuole functions

References

• Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S, etal. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003; 37: 1172–7.
   Google Scholar
• Calderone RA. Candida and candidiasis. 2002; Washington, DC: ASM Press. Volume 8, Number 8.
   Google Scholar
• Eggimann P, Garbino J, Pittet D. Management of Candida species infections in critically ill patients. Lancet Infect Dis. 2003; 3: 772–85.
   Google Scholar
• Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013; 4: 119–28.
   Google Scholar
• Rane HS, Bernardo SM, Raines SM, Binder JL, Parra KJ, Lee SA. Candida albicans VMA3 is necessary for V-ATPase assembly and function and contributes to secretion and filamentation. Eukaryot Cell. 2013; 12: 1369–82.
   Google Scholar
• Forster C, Kane PM. Cytosolic Ca2 + homeostasis is a constitutive function of the V-ATPase in Saccharomyces cerevisiae. J Biol Chem. 2000; 275: 38245–53.
   Google Scholar
• Huang C, Chang A. pH-dependent cargo sorting from the Golgi. J Biol Chem. 2011; 286: 10058–65.
   Google Scholar
• Zhang Y, Rao R. The V-ATPase as a target for antifungal drugs. Curr Protein Pept Sci. 2012; 13: 134–40.
   Google Scholar
• Kane PM. The where, when, and how of organelle acidification by the yeast vacuolar ATPase. Microbiol Mol Biol Rev. 2006; 70: 28872–81.
   Web of Science ®Google Scholar
• Zhang Z, Zheng Y, Mazon H, Milgrom E, Kitagawa N, Kish-Trier E, etal. Structure of the yeast vacuolar ATPase. J Biol Chem. 2008; 283: 35983–95.
   Google Scholar
• Zhang Y-Q, Gamarra S, Garcia-Effron G, Park S, Perlin DG, Rao R. Requirement for ergosterol in V-ATPase function underlies antifungal activity of azole drugs. PLOS Pathog. 2010; 6: e1000939.
   Google Scholar
• Chapman SW, Sullivan DC, Cleary JD. In search of the holy grail of antifungal therapy. Trans Am Clin Climatol Assoc. 2008; 119: 197–216. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• De Bernardis F, Mühlschlegel FA, Cassone A, Fonzi WA. The pH of the host niche controls gene expression in and virulence of Candida albicans. Infect Immun. 1998; 66: 3317–25. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Vylkova S, Carman AJ, Danhof HA, Collette JR, Zhou H, Lorenz MC. The fungal pathogen Candida albicans autoinduces hyphal morphogenesis by raising extracellular pH. mBio. 2011; 2: e00055–11.
   Google Scholar
• Sudbery PE. Growth of Candida albicans hyphae. Nat Rev Microbiol. 2011; 9: 737–48.
   Google Scholar
• Davis DA. How human pathogenic fungi sense and adapt to pH: the link to virulence. Curr Opin Microbiol. 2009; 12: 365–70.
   Google Scholar
• Ha KC, White TC. Effects of azole antifungal drugs on the transition from yeast cells to hyphae in susceptible and resistant isolates of the pathogenic yeast Candida albicans. Antimicrob Agents Chemother. 1999; 43: 763–8. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Zhang Y-Q, Rao R. Beyond ergosterol: linking pH to antifungal mechanisms. Virulence. 2010; 1: 551–4.
   Google Scholar
• Franke K, Nguyen M, Härtl A, Dahse HM, Vogl G, Würzner R, etal. The vesicle transport protein Vac1p is required for virulence of Candida albicans. Microbiology. 2006; 152: 3111–21.
   Google Scholar
• Poltermann S, Nguyen M, Günther J, Wendland J, Härtl A, Künkel W, etal. The putative vacuolar ATPase subunit Vma7p of Candida albicans is involved in vacuole acidification, hyphal development and virulence. Microbiology. 2005; 151: 1645–55.
   Google Scholar
• Patenaude C, Zhang Y, Cormack B, Köhler J, Rao R. Essential role for vacuolar acidification in Candida albicans virulence. J Biol Chem. 2013; 288: 26256–64.
   Google Scholar
• Tarsio M, Zheng H, Smardon AM, Martinez-Muñoz GA, Kane PM. Consequences of loss of Vph1 protein-containing vacuolar ATPases (V-ATPases) for overall cellular pH homeostasis. J Biol Chem. 2011; 286: 28089–96.
   Google Scholar
• Raines SM, Rane HS, Bernardo SM, Binder JL, Lee SA, Parra KJ. Deletion of vacuolar proton-translocating ATPase Voa isoforms clarifies the role of vacuolar pH as a determinant of virulence-associated traits in Candida albicans. J Biol Chem. 2013; 288: 6190–201.
   Google Scholar
• Maresova L, Muend S, Zhang YQ, Sychrova H, Rao R. Membrane hyperpolarization drives cation influx and fungicidal activity of amiodarone. J Biol Chem. 2009; 284: 2795–802.
   Google Scholar
• Muend S, Rao R. Fungicidal activity of amiodarone is tightly coupled to calcium influx. FEMS Yeast Res. 2008; 8: 425–31.
   Google Scholar
• Gamarra S, Rocha EMF, Zhang Y-Q, Park S, Rao R, Perlin DS. Mechanism of the synergistic effect of amiodarone and fluconazole on Candida albicans. Antimicrob Agents Chemother. 2010; 254: 1753–61.
   Google Scholar
• Guo Q, Sun S, Li Y, Shi C. In vitro interactions between azoles and amiodarone against clinical Candida albicans. Int J Antimicrob Agents. 2008; 31: 88–90.
   Google Scholar
• Ogita A, Fujita K-I, Tanaka T. Enhancing effects on vacuole-targeting fungicidal activity of amphotericin B. Front Microbiol. 2012; 3: 100.
   Google Scholar
• Hayek SR, Lee SA, Parra KJ. Advances in targeting the vacuolar protein-translocating ATPase (V-ATPase) for anti-fungal therapy. Front Pharmacol. 2014; 5: 1–8.
   Web of Science ®Google Scholar
• Bowman EJ, Graham LA, Stevens TH, Bowman BJ. The bafilomycin/concanamycin binding site in subunit c of the V-ATPase from Neurospora crassa and Saccharomyces cerevisiae. J Biol Chem. 2004; 279: 33131–8.
   Google Scholar
• Bowman EJ, Siehers A, Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPase from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A. 1988; 85: 7972–6.
   Google Scholar
• Bowman EJ, Bowman BJ. V-ATPase as drug targets. J Bioenerg Biomembr. 2005; 37: 431–5.
   Google Scholar
• Huss M, Wieczorek H. Inhibitors of V-ATPases: old and new players. J Exp Biol. 2009; 212: 341–6.
   Google Scholar
• Stylianou M, Kulesskiy E, Lopes JP, Granlund M, Wennerberg K, Urban CF. Antifungal application of non-antifungal drugs. Antimicrob Agents Chemother. 2014; 58: 1055–62.
   Google Scholar
• Chan C-Y, Prudom C, Raines SM, Charkhzarrin S, Melman SD, De Haro LP, etal. Inhibitors of V-ATPase proton transport reveal uncoupling functions of tether linking cytosolic and membrane domains of V0 subunit a (Vph1p). J Biol Chem. 2012; 287: 10236–50.
   Google Scholar
• Chau AS, Gurnani M, Hawkinson R, Laverdiere M, Cacciapouti A, McNicholas PM. Inactivation of sterol Δ5, 6-desaturase attenuates virulence in Candida albicans. Antimicrob Agents Chemother. 2005; 49: 3646–51.
   Google Scholar
• Saville SP, Lazzell AL, Bryant AP, Fretzen A, Monreal A, Solberg EO, etal. Inhibition of filamentation can be used to treat disseminated candidiasis. Antimicrob Agents Chemother. 2006; 50: 3312–16.
   Google Scholar
• Jacobsen ID, Wilson D, Wächtler B, Brunke S, Naglik JR, Hube B. Candida albicans dimorphism as a therapeutic agent. Expert Rev Anti Infect Ther. 2012; 10: 85–93.
   Google Scholar
• Wächtler B, Wilson D, Hube B. Candida albicans adhesion to and invasion and damage of vaginal epithelial cells: stage-specific inhibition by clotrimazole and bifonazole. Antimicrob Agents Chemother. 2011; 55: 4436–9.
   PubMed Web of Science ®Google Scholar